Medicine and Health Campaign

Advancing diabetes research

World-renowned scientists at the University of Minnesota are leading the way in developing advanced treatments and potential cures for type 1 and 2 diabetes, thanks to a community of charitable supporters.

Type 1 diabetes is caused by the immune system’s destruction of insulin-producing cells, known as islets, in the pancreas. University researchers established a standardized treatment for human islet-cell transplantation, which is now in the final stages of review by the U.S. Food and Drug Administration to become a routine medical procedure for treating type 1 diabetes in certain patients.

Philanthropic support makes discovery possible

With the help of charitable gifts, U scientists and physicians in the Schulze Diabetes Institute and Stem Cell Institute are:

  • seeking ways to prevent islets from being killed by the body and protect replaced or regenerated islets and organs in patients with type 1 diabetes
  • establishing an unlimited source of islet cells for transplantation using pig islets and creating insulin-producing islet cells from adult stem cells
  • participating in TrialNet, a global network of researchers working on diabetes prevention and early treatment
  • developing more effective ways to prevent, better manage, and reverse type 2 diabetes
  • providing surgical solutions and developing new drugs to address the challenges of diabetes

Your support can change lives. Give today.

View additional stories on Diabetes

U physician-scientists work on treatments and technologies that aim to better manage the disease—or stop it in its tracks. Read More »
After an intense illness and extensive TP-IAT surgery, the first grader is living a normal life. Read More »
A study fueled by philanthropy confirms that pancreatic islet cell transplantation can benefit people who have difficult-to-control type 1 diabetes. Read More »